+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Macular Edema"

US Macular Edema Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Macular Edema Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
From
From
North America Retinal Imaging Devices Market (2019-2025) - Product Thumbnail Image

North America Retinal Imaging Devices Market (2019-2025)

  • Report
  • January 2020
  • 75 Pages
  • North America
From
Macular Edema - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Macular Edema - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 350 Pages
  • Global
From
Diabetic Macular Edema Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Diabetic Macular Edema Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • March 2020
  • 421 Pages
  • Global
From
From
Loading Indicator

Macular Edema is a condition in which fluid accumulates in the macula, the central part of the retina responsible for sharp, central vision. It is a common complication of diabetes, and can also be caused by other diseases or conditions such as uveitis, retinal vein occlusion, and retinopathy of prematurity. Treatment options for macular edema include laser photocoagulation, intravitreal injections, and vitrectomy. Optical treatments for macular edema include laser photocoagulation, which uses a laser to reduce the amount of fluid in the macula. Intravitreal injections are also used to reduce fluid accumulation, and vitrectomy is a surgical procedure that removes the vitreous gel from the eye and replaces it with a gas bubble. Companies in the macular edema market include Regeneron Pharmaceuticals, Allergan, Novartis, Roche, and Bayer. Show Less Read more